English  |  正體中文  |  简体中文  |  2809385  
???header.visitor??? :  26988713    ???header.onlineuser??? :  536
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"lim sg"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-3 of 3  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
中山醫學大學 2020 ALT Levels for Asians With Metabolic Diseases: A Meta-analysis of 86 Studies With Individual Patient Data Validation Huang, DQ; Yeo, YH; Tan, E; Takahashi, H; Yasuda, S; Saruwatari, J; Tanaka, K; Oniki, K; Kam, LY; Muthiah, MD; Hyogo, H; Ono, M; Barnett, SD; Li, J; Zou, BY; Fung, J; Lee, TY; Wong, VWS; Yuen, MF; Dan, YY; Lim, SG; Cheung, R; Toyoda, H; Eguchi, Y; Nguyen, MH
中國醫藥大學 2015-01 Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B was associated with unexpected high rate of peripheral neuropathy (Marcellin P)*;(Wursthorn K);(Wedemeyer H);(Chuang WL);(Lau G);(Avila C);彭成元(Cheng-Yuan Peng);(Gane E);(Lim SG);(Fainboim H);(Foster GR);(Safadi R);(Rizzetto M);(Manns M);(Bao W);(Naoumov N)
高雄醫學大學 2006 Safety, tolerability and antiviral activity of pradefovir mesylate in patients with chronic hepatitis b virus infection: 48-week analysis of a phase 2 study  Lee, KS;Lim, SG;莊萬龍;Hwang, SG;Cho, M;Lai, MY;Chao, YC;Chang, TT;Han, KH;Lee, CM;Um, SH;Yeon, JE;Yang, SS;Teo, EK;Peng, CY;Lin, HH;Yang, SS;Huo , TI

Showing items 1-3 of 3  (1 Page(s) Totally)
1 
View [10|25|50] records per page